HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephan Petersenn Selected Research

pasireotide

2/2020Use of late-night salivary cortisol to monitor response to medical treatment in Cushing's disease.
12/2019Long-term efficacy and safety of once-monthly pasireotide in Cushing's disease: A Phase III extension study.
1/2018Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial.
11/2016Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing's disease: 12-month, Phase III pasireotide study.
12/2015How to manage pasireotide, when using as medical treatment for Cushing's disease.
11/2014Pharmacokinetics, pharmacodynamics, and safety of pasireotide LAR in patients with acromegaly: a randomized, multicenter, open-label, phase I study.
9/2014Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study.
4/2014Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study.
8/2013New avenues in the medical treatment of Cushing's disease: corticotroph tumor targeted therapy.
7/2012Pasireotide (SOM230), a novel multireceptor-targeted somatostatin analogue, is well tolerated when administered as a continuous 7-day subcutaneous infusion in healthy male volunteers.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephan Petersenn Research Topics

Disease

24Neoplasms (Cancer)
11/2021 - 04/2004
17Pituitary ACTH Hypersecretion
12/2021 - 12/2009
16Acromegaly
11/2021 - 06/2007
15Cushing Syndrome
10/2022 - 03/2006
13Adenoma (Adenomas)
03/2021 - 04/2004
12Pituitary Neoplasms (Pituitary Adenoma)
03/2021 - 05/2010
8Carcinoma (Carcinomatosis)
06/2020 - 02/2002
8Pheochromocytoma
11/2009 - 11/2004
5Hyperaldosteronism (Conn Syndrome)
05/2008 - 04/2004
4Hyperglycemia
04/2015 - 03/2012
4Adrenal Insufficiency (Adrenal Gland Hypofunction)
04/2015 - 01/2009
3Neuroendocrine Tumors (Neuroendocrine Tumor)
07/2021 - 12/2011
2Neoplasm Metastasis (Metastasis)
06/2020 - 01/2018
2Prolactinoma (Prolactinomas)
04/2019 - 05/2010
2Adrenocortical Adenoma (Disease, Conn's)
01/2018 - 11/2004
2ACTH-Secreting Pituitary Adenoma
08/2013 - 09/2012
2Hypertension (High Blood Pressure)
08/2010 - 03/2006
2Pituitary Diseases (Disease, Anterior Pituitary)
03/2010 - 01/2009
2Prader-Willi Syndrome (Syndrome, Prader-Willi)
07/2009 - 03/2007
2Hyperplasia
05/2008 - 12/2004
2AIDS-Related Complex (ARC)
08/2006 - 04/2004
1Disease Progression
06/2020
1Hyperprolactinemia
02/2020
1Craniopharyngioma (Craniopharyngiomas)
01/2020
1Hypocalcemia
12/2019
1Hypoparathyroidism
12/2019
1Hypophysitis
04/2019
1Hypopituitarism (Sheehan's Syndrome)
04/2019
1Pituitary Apoplexy
04/2019
1Thrombosis (Thrombus)
01/2018
1Endocrine System Diseases (Endocrine Diseases)
06/2015
1Inflammation (Inflammations)
07/2011
1Diabetes Mellitus
08/2010
1Acquired Immunodeficiency Syndrome (AIDS)
06/2010
1Parkinson Disease (Parkinson's Disease)
05/2010
1Adrenal incidentaloma
11/2009
1Hemangioma (Angioma)
11/2009
1Oncogenic osteomalacia
11/2009
1Type 2 Diabetes Mellitus (MODY)
08/2009
1Chronic Kidney Failure (Chronic Renal Failure)
02/2009
1Renal Insufficiency (Renal Failure)
02/2009
1Injection Site Reaction
09/2008
1Lipodystrophy
09/2008
1Headache (Headaches)
09/2008

Drug/Important Bio-Agent (IBA)

18Hydrocortisone (Cortisol)FDA LinkGeneric
10/2022 - 03/2006
12pasireotideIBA
02/2020 - 05/2010
10Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
07/2021 - 04/2008
8Adrenocorticotropic Hormone (ACTH)FDA Link
03/2021 - 04/2006
7Growth Hormone (Somatotropin)IBA
11/2021 - 03/2007
7lanreotide (Somatuline)FDA Link
07/2021 - 04/2014
7AldosteroneIBA
01/2018 - 04/2004
6Dexamethasone (Maxidex)FDA LinkGeneric
10/2022 - 03/2006
6Somatostatin Receptors (Somatostatin Receptor)IBA
03/2021 - 11/2004
6Insulin-Like Growth Factor I (IGF-1)IBA
03/2021 - 09/2008
5Temozolomide (Temodar)FDA LinkGeneric
03/2021 - 01/2018
4GhrelinIBA
08/2009 - 03/2007
4Octreotide (Sandostatin)FDA LinkGeneric
04/2008 - 04/2006
3Pharmaceutical PreparationsIBA
03/2021 - 09/2012
3APTIBA
06/2020 - 01/2018
3Insulin (Novolin)FDA Link
04/2020 - 02/2016
3Hormones (Hormone)IBA
04/2019 - 02/2009
3Glucose (Dextrose)FDA LinkGeneric
04/2017 - 03/2007
3GlucocorticoidsIBA
11/2012 - 08/2007
3ReninIBA
08/2006 - 04/2004
3CatecholaminesIBA
08/2006 - 03/2006
2LigandsIBA
06/2020 - 01/2013
2ProlactinIBA
02/2020 - 02/2007
2Dopamine Agonists (Dopamine Agonist)IBA
04/2019 - 05/2010
2Biomarkers (Surrogate Marker)IBA
11/2016 - 04/2015
2Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
04/2015 - 09/2012
2Mifepristone (RU 486)FDA Link
04/2015 - 09/2012
2pegvisomantFDA LinkGeneric
08/2010 - 09/2008
1Insulin-Like PeptidesIBA
11/2021
1Bevacizumab (Avastin)FDA Link
03/2021
1Peptides (Polypeptides)IBA
06/2020
1Parathyroid Hormone (Parathormone)IBA
12/2019
1CXCR ReceptorsIBA
01/2018
1Chemokine ReceptorsIBA
01/2018
1Cytochrome P-450 CYP11B2 (CYP11B2)IBA
01/2018
1LipidsIBA
04/2017
1Dopamine (Intropin)FDA LinkGeneric
08/2013
1gallium Ga 68 dotatateIBA
12/2011
1Ga(III)-DOTATOCIBA
12/2011
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
08/2010
1LDL Lipoproteins (beta Lipoproteins)IBA
08/2010
1CholesterolIBA
08/2010
1HDL LipoproteinsIBA
08/2010
1GonadotropinsIBA
06/2010
1Estradiol (Delestrogen)FDA LinkGeneric
06/2010
1CabergolineFDA LinkGeneric
05/2010
1Ghrelin ReceptorsIBA
08/2009
1SecretagoguesIBA
02/2009
1EnzymesIBA
09/2008

Therapy/Procedure

22Therapeutics
03/2021 - 03/2006
5Drug Therapy (Chemotherapy)
03/2021 - 05/2010
3Adrenalectomy
06/2010 - 12/2004
2Operative Surgical Procedures
05/2008 - 05/2006
1Radiotherapy
12/2021
1Combined Modality Therapy
06/2020
1Kidney Transplantation
02/2009